 Tardive dyskinesia Tardive dyskinesia irreversible syndrome involuntary hyperkinetic movements predisposed persons neuroleptic antipsychotic drug therapy choreoathetoid dyskinesias orofacial limb truncal regions subtypes syndrome tardive dystonia tardive akathisia mechanisms pathogenesis pathophysiology disorder unproven dopaminergic functions role explanation Tardive dyskinesia neuroleptic-treated patients high-risk groups elderly rates Risk factors age female sex affective disorders psychotic diagnoses patients drugs antidopaminergic activity nausea gastrointestinal dysfunction periods Total drug exposure tardive dyskinesia risk Management strategies careful evaluation psychiatric neurologic states broad differential diagnosis adjustment neuroleptic agents effective dose psychosis minimizes motor side effects drug therapy uniformly safe effective disorder favorable long-term outcome improvement resolution correlates age early detection drug exposure duration follow-up